Caffeine

Caffeine

SCHEMBL901194

Cn1c(=O)c2c(ncn2C)n(C)c1=O.Cn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3

The experimentally established mechanism targets of Caffeine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B known ✓ P29275 10/20 1.00
ADORA2A known ✓ P29274 2/20 1.00
ADORA3 known ✓ P0DMS8 1/20 1.00
ADORA1 known ✓ P30542 1/20 1.00
PIK3CD O00329 1/20 1.00
POLB P06746 1/20 1.00
CNR1 P21554 1/20 1.00
ACHE P22303 1/20 1.00
NTSR1 P30989 1/20 1.00
MC3R P41968 1/20 1.00
NOTUM Q6P988 1/20 1.00
SIRT3 Q9NTG7 1/20 1.00
GDA Q9Y2T3 1/20 1.00
NR2E1 Q9Y466 1/20 1.00
PDE4A P27815 1/20 0.65
PDE4B Q07343 1/20 0.65
PDE4C Q08493 1/20 0.65
PDE4D Q08499 1/20 0.65
MAPT P10636 1/20 0.60
LMNA P02545 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Caffeine SCHEMBL5671 1.00 ADORA2B (1.00) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL29590919 1.00 ADORA2B (1.00) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL29549224 1.00 ADORA2B (1.00) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL10478364 1.00 ADORA2B (1.00) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL29549294 1.00 ADORA2B (1.00) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL8569482 1.00 ADORA2B (1.00) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL23004680 0.98 ADORA2B (0.96) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL2496249 0.98 ADORA2B (0.96) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL165192 0.98 ADORA2B (0.96) ADORA2BADORA2APIK3CDPOLBADORA3
Caffeine SCHEMBL20637756 0.98 ADORA2B (0.96) ADORA2BADORA2APIK3CDPOLBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354140-B1 PROCESS FOR MANUFACTURE OF A HEALTH-PROMOTING FRUIT ENERGY DRINK LA SAD TRADE SP Z O O (PL) 2021-08-18 EP claimed
CN-105343097-A Composition containing caffeine and application and manufacturing method of composition containing caffeine TIANJIN JIANLAIDE TECHNOLOGY CO LTD 2016-02-24 CN claimed
US-11062794-B2 Olfactory signature and odorant mixture having the same YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-07-13 US disclosed
WO-2021103170-A1 NON-BITTER-TASTE BITTER GOURD TRITERPENOID COMPOSITION FOR INHIBITING LIVER GLUCONEOGENESIS AND APPLICATION THEREOF 广东省农业科学院蚕业与农产品加工研究所 2021-06-03 WO disclosed
CN-110734996-B Molecular markers linked with caffeine content of tea tree and application thereof 广东省农业科学院茶叶研究所 2020-09-08 CN disclosed
CN-110734996-A group molecular marker linked with caffeine content of tea tree and application thereof 广东省农业科学院茶叶研究所 2020-01-31 CN disclosed
CN-109645189-A A method of utilizing coffee drupe extracting caffeine 廊坊市维金农业科技有限公司 2019-04-19 CN disclosed
CN-109152380-A The material for adsorbing caffeine, the system for adsorbing caffeine, the correlation technique for going the system of caffeine and removing caffeine from solution 迪卡提诺股份有限公司 2019-01-04 CN disclosed
US-20180253534-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-09-06 US disclosed
EP-3220882-A1 HAIR CARE COMPOSITIONS COMPRISING DEHYDROXANTHAN GUM The Procter and Gamble Company (US) 2017-09-27 EP disclosed
EP-3209372-A1 STIMULATION DEVICES AND METHODS FOR TREATING DRY EYE Oculeve, Inc. (US) 2017-08-30 EP disclosed
US-5773219-A IRRADIATING CELL CULTURE WITH FLORESCENT LIGHT; ADDING CAFFEINE; INCUBATION THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-06-30 US disclosed
WO-1993019741-A1 A pharmaceutical formulation BENZON PHARMA A/S (DK) 1993-10-14 WO disclosed
EP-0417256-A4 NOVEL N-(SULFOMETHYL)-N'-ARYLUREAS 1991-09-25 EP disclosed
EP-0417256-A1 NOVEL N-(SULFOMETHYL)-N'-ARYLUREAS. NUTRASWEET CO (US) 1991-03-20 EP disclosed
WO-1990011695-A1 NOVEL N-(SULFOMETHYL)-N'-ARYLUREAS THE NUTRASWEET COMPANY (US) 1990-10-18 WO disclosed
US-4904773-A FORMING COMPLEXES WITH CYCLODEXTRIN ALLELIX INC. (CA) 1990-02-27 US disclosed
US-4877631-A TREATMENT WITH AN ACID DOUWE EGBERTS KONINKLIJKE TABAKSFABRIEK-KOFFIEBRANDERIJEN-THEEHANDEL N.V. (NL) 1989-10-31 US disclosed
US-4331694-A Removal of caffeine by selective adsorption using zeolite adsorbents UNION CARBIDE CORPORATION (US) 1982-05-25 US disclosed
US-4160042-A DECAFFEINATION, DEACIDIFICATION FARR DAVID R 1979-07-03 US disclosed